Research conducted at Pfizer Inc. has provided new information about adverse drug reactions

Data detailed in "Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions" have been presented. According to recent research published in the journal Drug Safety, "Various data mining algorithms (DMAs) that perform disporportionality analysis on spontaneous reporting system (SRS) data are being heavily promoted to improve drug safety surveillance. The incremental value of DMAs is ultimately related to their ability to detect truly unexpected associations that would have escaped traditional surveillance and/or their ability to identify the same associations as traditional methods but with greater scientific efficiency."

"As...

Want to see the full article?

• Purchase this article for only $3.00